SAN FRANCISCO, Nov. 2 /PRNewswire/ -- The Neurotechnology Industry Organization (NIO) today announced the top ten emerging areas of neuroscience that will impact the future of treatments for brain and nervous system. According to NIO, the trade association that represents the 500 companies worldwide developing treatments for the brain and nervous system, the U.S. economic burden of brain-related disorders has reached more than $1 trillion, highlighting the acute need for continued neuroscience research and therapeutic development.
"Advances across a wide spectrum of neuroscience research are making possible the development of more effective treatments for the nearly 100 million Americans and 2 billion people worldwide that currently suffer from brain-related illnesses," said Zack Lynch, Executive Director of NIO.
NIO has developed this "top ten" list in anticipation of cutting edge research being presented at The Society for Neuroscience Conference being held in San Diego, California, November 3-7. NIO will be hosting a booth (#4311) and neurotech industry partnering social at the conference.
About the Neurotechnology Industry Organization
The Neurotechnology Industry Organization (NIO) is the trade association representing companies involved in neuroscience -- drugs, devices and diagnostics, brain research centers, and advocacy groups across the world. More information can be found at http://www.neurotechindustry.org
CONTACT: Zack Lynch of Neurotechnology Industry Organization,
+1-415-341-0193, email@example.com; Ross Gillfillan of Feinstein
Kean Healthcare, +1-415-503-0197, firstname.lastname@example.org
Web site: http://www.neurotechindustry.org/